P

Inventor

YAMNIUK AARON P

US19 patents
⚠️ This page may combine multiple inventors who share the name “YAMNIUK AARON P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

18 patents
US8853154B2Oct 7, 2014

Fibronectin based scaffold domain proteins that bind to myostatin

BRISTOL MYERS SQUIBB CO35 citations96
US10100129B2Oct 16, 2018

Antibodies against CD73 and uses thereof

BRISTOL MYERS SQUIBB CO24 citations93
US9605080B2Mar 28, 2017

Antibodies against CD73

BRISTOL MYERS SQUIBB CO31 citations93
US9493546B2Nov 15, 2016

Fibronectin based scaffold domain proteins that bind to myostatin

BRISTOL MYERS SQUIBB CO14 citations91
US10653791B2May 19, 2020

Antibodies comprising modified heavy constant regions

BRISTOL MYERS SQUIBB CO10 citations83
US11213586B2Jan 4, 2022

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)

BRISTOL MYERS SQUIBB CO5 citations72
US10245302B2Apr 2, 2019

Fibronectin based scaffold domain proteins that bind to myostatin

BRISTOL MYERS SQUIBB CO1 citations72
US10167343B2Jan 1, 2019

Antibodies against CD73

BRISTOL MYERS SQUIBB CO3 citations71
US11919954B2Mar 5, 2024

Anti-TREM-1 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO1 citations69
US11155618B2Oct 26, 2021

Anti-TREM-1 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO1 citations69
US11952427B2Apr 9, 2024

Anti-CD40 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO0 citations61
US11813315B2Nov 14, 2023

Fibronectin based scaffold domain proteins that bind to myostatin

BRISTOL MYERS SQUIBB CO0 citations61
US11512124B2Nov 29, 2022

Fibronectin type III domain proteins with enhanced solubility

BRISTOL MYERS SQUIBB CO0 citations61
US11352440B2Jun 7, 2022

Antibodies against CD73 and uses thereof

BRISTOL MYERS SQUIBB CO0 citations61
US11306149B2Apr 19, 2022

Anti-CD40 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO1 citations61
US10787498B2Sep 29, 2020

Fibronectin type III domain proteins with enhanced solubility

BRISTOL MYERS SQUIBB CO1 citations61
US11952420B2Apr 9, 2024

Nucleic acids encoding anti-TREM-1 antibodies

BRISTOL MYERS SQUIBB CO0 citations59
US10844130B2Nov 24, 2020

Nucleic acids encoding an anti-CD40 antibody

BRISTOL MYERS SQUIBB CO0 citations50

UNIV ROCKEFELLER

1 patent